DE60103503D1 - Verwendung von fsh zur behandlung von infertilität - Google Patents

Verwendung von fsh zur behandlung von infertilität

Info

Publication number: DE60103503D1
Authority: DE; Germany
Prior art keywords: fsh; treat infertility; infertility; treat
Prior art date: 2000-01-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60103503T

Other languages

English (en)

Other versions

DE60103503T2 (de

DE60103503T3 (de

Inventor

Ernest Loumaye

Louise Duerr-Meyers

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Serono SA

Original Assignee

Applied Research Systems ARS Holding NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-27

Filing date

2001-01-09

Publication date

2004-07-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60103503(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-04 Priority claimed from EP00302840A external-priority patent/EP1142582A1/de

2001-01-09 Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV

2004-07-01 Publication of DE60103503D1 publication Critical patent/DE60103503D1/de

2005-06-09 Publication of DE60103503T2 publication Critical patent/DE60103503T2/de

2008-12-24 Application granted granted Critical

2008-12-24 Publication of DE60103503T3 publication Critical patent/DE60103503T3/de

2021-01-10 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE60103503T 2000-01-27 2001-01-09 Verwendung von fsh zur behandlung von infertilität Expired - Lifetime DE60103503T3 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
EP00300591		2000-01-27
EP00300591		2000-01-27
EP00302840		2000-04-04
EP00302840A EP1142582A1 (de)	2000-04-04	2000-04-04	Verwendung von FSH zur Behandlung von Infertilität
PCT/GB2001/000065 WO2001054715A1 (en)	2000-01-27	2001-01-09	Use of fsh for treating infertility

Publications (3)

Publication Number	Publication Date
DE60103503D1 true DE60103503D1 (de)	2004-07-01
DE60103503T2 DE60103503T2 (de)	2005-06-09
DE60103503T3 DE60103503T3 (de)	2008-12-24

Family

ID=26072975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60103503T Expired - Lifetime DE60103503T3 (de)	2000-01-27	2001-01-09	Verwendung von fsh zur behandlung von infertilität

Country Status (29)

Country	Link
US (1)	US7291593B2 (de)
EP (2)	EP1442748A1 (de)
JP (1)	JP5170928B2 (de)
KR (2)	KR100871502B1 (de)
CN (1)	CN1418107A (de)
AR (1)	AR027287A1 (de)
AT (1)	ATE267608T1 (de)
AU (1)	AU783121B2 (de)
BG (1)	BG65915B1 (de)
BR (1)	BR0107881A (de)
CA (1)	CA2397680A1 (de)
CZ (1)	CZ302835B6 (de)
DE (1)	DE60103503T3 (de)
DK (1)	DK1250148T4 (de)
EA (1)	EA004924B1 (de)
EE (1)	EE05444B1 (de)
ES (1)	ES2217113T5 (de)
HR (1)	HRP20020630A2 (de)
HU (1)	HU230833B1 (de)
IL (2)	IL150837A0 (de)
MX (1)	MXPA02007233A (de)
NO (1)	NO324626B1 (de)
PL (1)	PL211113B1 (de)
PT (1)	PT1250148E (de)
RS (1)	RS50805B (de)
SI (1)	SI1250148T2 (de)
SK (1)	SK287717B6 (de)
TR (1)	TR200401810T4 (de)
WO (1)	WO2001054715A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2457851A1 (en)	2001-09-12	2003-03-20	Applied Research Systems Ars Holding N.V.	Use of hcg and lh in controlled ovarian hyperstimulation
HRP20040087A2 (en) *	2001-09-12	2004-12-31	Applied Research Systems	USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
AU2002324183B2 (en) *	2001-09-12	2007-10-25	Merck Serono Sa	Use of hCG and LH in controlled ovarian hyperstimulation
UA88879C2 (en) *	2003-09-02	2009-12-10	Эплайд Рисерч Системз Эрс Холдинг Н.В.	Fsh glycosylation mutant
US7481748B2 (en) *	2005-09-22	2009-01-27	Kurt Manufacturing Company, Inc.	Locking mechanism for a bicycle trainer
EP2150271A1 (de) *	2007-05-11	2010-02-10	The Texas A & M Univsersity System	Hormonnormalisierungstherapie und ihre verwendung
AR081755A1 (es) *	2010-04-02	2012-10-17	Hanmi Holdings Co Ltd	Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CA2934579A1 (en) *	2013-12-20	2015-06-25	Fertilify Inc.	Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
HRP20211802T1 (hr) *	2017-09-01	2022-03-04	Ferring B.V.	Pripravak za kontroliranu stimulaciju jajnika

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4725579A (en) *	1985-02-21	1988-02-16	Serono Laboratories, Inc.	Method of in vitro fertilization by a unique combination of gonadotropins

2001
- 2001-01-09 MX MXPA02007233A patent/MXPA02007233A/es active IP Right Grant
- 2001-01-09 EE EEP200200415A patent/EE05444B1/xx unknown
- 2001-01-09 WO PCT/GB2001/000065 patent/WO2001054715A1/en not_active Ceased
- 2001-01-09 PL PL356925A patent/PL211113B1/pl unknown
- 2001-01-09 SI SI200130111T patent/SI1250148T2/sl unknown
- 2001-01-09 KR KR1020027009518A patent/KR100871502B1/ko not_active Expired - Lifetime
- 2001-01-09 AT AT01900491T patent/ATE267608T1/de active
- 2001-01-09 AU AU25321/01A patent/AU783121B2/en not_active Expired
- 2001-01-09 EA EA200200801A patent/EA004924B1/ru not_active IP Right Cessation
- 2001-01-09 DE DE60103503T patent/DE60103503T3/de not_active Expired - Lifetime
- 2001-01-09 HR HRP20020630 patent/HRP20020630A2/hr not_active Application Discontinuation
- 2001-01-09 JP JP2001554698A patent/JP5170928B2/ja not_active Expired - Lifetime
- 2001-01-09 US US10/182,138 patent/US7291593B2/en not_active Expired - Lifetime
- 2001-01-09 CN CN01806573A patent/CN1418107A/zh active Pending
- 2001-01-09 DK DK01900491T patent/DK1250148T4/da active
- 2001-01-09 EP EP04006375A patent/EP1442748A1/de not_active Withdrawn
- 2001-01-09 KR KR1020077017998A patent/KR100871499B1/ko not_active Expired - Lifetime
- 2001-01-09 ES ES01900491T patent/ES2217113T5/es not_active Expired - Lifetime
- 2001-01-09 CZ CZ20022555A patent/CZ302835B6/cs not_active IP Right Cessation
- 2001-01-09 SK SK1096-2002A patent/SK287717B6/sk not_active IP Right Cessation
- 2001-01-09 IL IL15083701A patent/IL150837A0/xx unknown
- 2001-01-09 EP EP01900491A patent/EP1250148B2/de not_active Expired - Lifetime
- 2001-01-09 CA CA002397680A patent/CA2397680A1/en not_active Abandoned
- 2001-01-09 RS YUP-567/02A patent/RS50805B/sr unknown
- 2001-01-09 TR TR2004/01810T patent/TR200401810T4/xx unknown
- 2001-01-09 PT PT01900491T patent/PT1250148E/pt unknown
- 2001-01-09 BR BR0107881-0A patent/BR0107881A/pt not_active Application Discontinuation
- 2001-01-09 HU HU0204324A patent/HU230833B1/hu unknown
- 2001-01-25 AR ARP010100325A patent/AR027287A1/es unknown
2002
- 2002-07-11 NO NO20023354A patent/NO324626B1/no not_active IP Right Cessation
- 2002-07-22 IL IL150837A patent/IL150837A/en active IP Right Grant
- 2002-07-23 BG BG106943A patent/BG65915B1/bg unknown

Also Published As

Publication number	Publication date
HRP20020630A2 (en)	2004-12-31
NO20023354D0 (no)	2002-07-11
BR0107881A (pt)	2003-04-01
AR027287A1 (es)	2003-03-19
NO324626B1 (no)	2007-11-26
MXPA02007233A (es)	2003-02-12
DK1250148T4 (da)	2008-09-22
PT1250148E (pt)	2004-09-30
PL356925A1 (en)	2004-07-12
WO2001054715A1 (en)	2001-08-02
EA200200801A1 (ru)	2003-02-27
RS50805B (sr)	2010-08-31
YU56702A (sh)	2005-09-19
EP1250148A1 (de)	2002-10-23
CA2397680A1 (en)	2001-08-02
HU230833B1 (hu)	2018-07-30
SK287717B6 (en)	2011-07-06
TR200401810T4 (tr)	2004-09-21
SI1250148T2 (sl)	2008-10-31
DK1250148T3 (da)	2004-08-16
HUP0204324A3 (en)	2004-12-28
HUP0204324A2 (en)	2003-05-28
JP2003520823A (ja)	2003-07-08
ES2217113T5 (es)	2008-11-01
ES2217113T3 (es)	2004-11-01
DE60103503T2 (de)	2005-06-09
JP5170928B2 (ja)	2013-03-27
ATE267608T1 (de)	2004-06-15
AU2532101A (en)	2001-08-07
KR100871499B1 (ko)	2008-12-05
CZ302835B6 (cs)	2011-11-30
US20030158106A1 (en)	2003-08-21
EA004924B1 (ru)	2004-10-28
AU783121B2 (en)	2005-09-29
BG106943A (bg)	2003-02-28
KR20020081273A (ko)	2002-10-26
NO20023354L (no)	2002-09-24
SI1250148T1 (en)	2004-08-31
US7291593B2 (en)	2007-11-06
EP1442748A1 (de)	2004-08-04
KR100871502B1 (ko)	2008-12-05
EE200200415A (et)	2003-12-15
SK10962002A3 (sk)	2002-12-03
EE05444B1 (et)	2011-08-15
CN1418107A (zh)	2003-05-14
IL150837A (en)	2010-12-30
DE60103503T3 (de)	2008-12-24
EP1250148B2 (de)	2008-07-02
BG65915B1 (bg)	2010-05-31
PL211113B1 (pl)	2012-04-30
KR20070087253A (ko)	2007-08-27
CZ20022555A3 (cs)	2002-11-13
IL150837A0 (en)	2003-02-12
EP1250148B1 (de)	2004-05-26

Publication	Publication Date	Title
EP1324780A4 (de)	2005-06-22	Methoden zur behandlung von herzarrhythmie
ATE365042T1 (de)	2007-07-15	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE419856T1 (de)	2009-01-15	Verwendung von rimexolon zur behandlung von augentrockenheit
ATE401909T1 (de)	2008-08-15	Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
ATE308364T1 (de)	2005-11-15	Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE288748T1 (de)	2005-02-15	Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60105295D1 (de)	2004-10-07	Chinazolinderivate zur behandlung von tumoren
DE60103770D1 (de)	2004-07-15	Botulinumtoxin zur behandlung endokriner erkrankungen
ATE353218T1 (de)	2007-02-15	Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60123238D1 (de)	2006-11-02	Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
ATE338552T1 (de)	2006-09-15	Verwendungen von et743 zur behandlung von krebs
ATE279386T1 (de)	2004-10-15	Retinoide zur behandlung von emphysem
ATE254913T1 (de)	2003-12-15	Diacerein zur behandlung von psoriasis
DE60130661D1 (de)	2007-11-08	Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE339955T1 (de)	2006-10-15	Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
ATE218862T1 (de)	2002-06-15	Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE267608T1 (de)	2004-06-15	Verwendung von fsh zur behandlung von infertilität
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
DE60104791D1 (de)	2004-09-16	Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE60103685D1 (de)	2004-07-15	Behandlung von Poriomania
ATE317261T1 (de)	2006-02-15	Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60120990D1 (de)	2006-08-03	Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE270545T1 (de)	2004-07-15	Verwendung von nmda antagonisten zur behandlung des reizkolons
ATE404203T1 (de)	2008-08-15	Verwendung von desoxypeganin zur behandlung der klinischen depression

Legal Events

Date	Code	Title	Description
2005-05-25	8363	Opposition against the patent
2008-06-12	8327	Change in the person/name/address of the patent owner	Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH
2008-09-04	8366	Restricted maintained after opposition proceedings
2008-11-06	8328	Change in the person/name/address of the agent	Representative=s name: WEICKMANN & WEICKMANN, 81679 MUENCHEN